Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia. | Sci Adv | 2022 | 35061527 | PubTator, text mining | PubMed |
| Atomically Resolved Electrically Active Intragrain Interfaces in Perovskite Semiconductors. | J Am Chem Soc | 2022 | 35060705 | PubTator, text mining | PubMed |
| Changes in Glycated Human Serum Albumin Binding Affinity for Losartan in the Presence of Fatty Acids In Vitro Spectroscopic Analysis. | Molecules | 2022 | 35056715 | PubTator, text mining | PubMed |
| Excited States Computation of Models of Phenylalanine Protein Chains: TD-DFT and Composite CC2/TD-DFT Protocols. | Int J Mol Sci | 2022 | 35054802 | PubTator, text mining | PubMed |
| Fanconi Anemia: Examining Guidelines for Testing All Patients with Hand Anomalies Using a Machine Learning Approach. | Children (Basel) | 2022 | 35053710 | PubTator, text mining | PubMed |
| Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma. | Cancers (Basel) | 2022 | 35053435 | PubTator, text mining | PubMed |
| Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through. | Biomedicines | 2022 | 35052787 | PubTator, text mining | PubMed |
| Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology. | Cancer Treat Rev | 2022 | 35051883 | PubTator, text mining | PubMed |
Apolipoprotein B mRNA-Editing Catalytic Polypeptide-Like-Induced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Throughout Disease Progression. | JCO Precis Oncol | 2022 | 35050709 | PubTator, text mining | PubMed |
| The neglected members of the family: non-BRCA mutations in the Fanconi anemia/BRCA pathway and reproduction. | Hum Reprod Update | 2022 | 35043201 | PubTator, text mining | PubMed |
| A new signature based on alternative polyadenylation for prognostic prediction and therapeutic responses in low-grade glioma. | Aging (Albany NY) | 2022 | 35042833 | PubTator, text mining | PubMed |
| PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response. | Adv Sci (Weinh) | 2022 | 35037428 | PubTator, text mining | PubMed |
| Shared genetic liability between major depressive disorder and osteoarthritis. | Bone Joint Res | 2022 | 35023758 | PubTator, text mining | PubMed |
| KDM6A Depletion in Breast Epithelial Cells Leads to Reduced Sensitivity to Anticancer Agents and Increased TGFβ Activity. | Mol Cancer Res | 2022 | 35022315 | PubTator, text mining | PubMed |
| Age influences on the molecular presentation of tumours. | Nat Commun | 2022 | 35017538 | PubTator, text mining | PubMed |
| Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. | Nat Med | 2022 | 35013615 | PubTator, text mining | PubMed |
| Comprehensive Molecular Landscape of Cetuximab Resistance in Head and Neck Cancer Cell Lines. | Cells | 2022 | 35011716 | PubTator, text mining | PubMed |
| First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations. | IJU Case Rep | 2022 | 35005470 | PubTator, text mining | PubMed |
| BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia. | Sci Rep | 2022 | 34997070 | PubTator, text mining | PubMed |
| Pancytopenia and thrombosis defects in zebrafish mutants of Fanconi anemia genes. | Blood Cells Mol Dis | 2022 | 34991062 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=54